Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bone Biologics (NASDAQ:BBLG) through any online brokerage.
Other companies in Bone Biologics’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Bio Green Med Solution Inc (NASDAQ:BGMSP), Can Fite Biofarma Ltd (AMEX:CANF), AquaBounty Technologies Inc (NASDAQ:AQB) and Indaptus Therapeutics Inc (NASDAQ:INDP).
Bone Biologics has a consensus price target of $2.25.
The stock price for Bone Biologics (NASDAQ: BBLG) is $2.07 last updated December 10, 2025 at 6:47 PM EST.
There are no upcoming dividends for Bone Biologics.
Bone Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for Bone Biologics.
Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.